Physician profile
Laura Bishop
NPI 1750306858
$3,968.97
in general payments reported to CMS, 2019-2025
32 companies · $979 in 2025
The $979 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $739 · 2020: $364 · 2021: $412 · 2022: $708 · 2023: $492 · 2024: $276 · 2025: $979.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,223 · Travel and Lodging: $523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,223.39 |
| Travel and Lodging | $522.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $636.70 | 2019-2025 | Injectafer |
| Medtronic, INC. | $574.18 | 2023-2025 | Interstim, Truclear |
| Abbvie INC. | $512.08 | 2019-2025 | Lo Loestrin Fe, Orilissa |
| Amgen INC. | $266.36 | 2019-2021 | |
| Channel Medsystems, INC. | $228.47 | 2022-2023 | |
| Pfizer INC. | $227.49 | 2019-2024 | |
| Hologic Sales and Service, LLC | $200.68 | 2019-2025 | Myosure Tissue Removal Device, Acessa Provu System, Omni Hysteroscope |
| Therapeuticsmd, INC. | $134.83 | 2019-2022 | |
| Boston Scientific Corporation | $132.85 | 2019-2025 | Axonics |
| Astrazeneca Pharmaceuticals Lp | $125.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $124.29 | 2019-2024 | |
| Astellas Pharma US INC | $95.00 | 2023-2025 | Veozah |
| Shield Therapeutics INC | $87.35 | 2024-2025 | |
| Organon LLC | $65.47 | 2022-2025 | Jada System |
| Exeltis, USA INC. | $63.33 | 2024-2025 | Slynd |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $60.91 | 2022-2023 | Wegovy |
| Mylan Pharmaceuticals INC. | $56.00 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $41.86 | 2024 | Exparel |
| Davol INC. | $41.45 | 2023 | Arista Ah Flexitip |
| Minerva Surgical, INC | $40.01 | 2021-2022 | |
| Lupin INC. | $34.00 | 2019-2020 | |
| Myovant Sciences INC. | $29.59 | 2021 | |
| Coopersurgical, INC. | $28.47 | 2020-2022 | |
| Evofem Biosciences, INC. | $26.23 | 2021 | |
| Amag Pharmaceuticals, INC. | $24.40 | 2019 | |
| Biogen, INC. | $22.12 | 2025 | Zurzuvae |
| Duchesnay USA Incorporated | $19.25 | 2019 | |
| Roche Diagnostics Corporation | $18.45 | 2019 | |
| Merck Sharp & Dohme LLC | $15.35 | 2022 | |
| Mayne Pharma Commercial LLC | $13.62 | 2021 | |
| Avion Pharmaceuticals | $12.20 | 2021 | |
| Allergan, INC. | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Bishop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.